Status:

UNKNOWN

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Lead Sponsor:

Sohag University

Conditions:

Visceral Fat

Insulin Resistance

Eligibility:

All Genders

18-65 years

Brief Summary

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Detailed Description

The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by ...

Eligibility Criteria

Inclusion

  • Age \> 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study

Exclusion

  • Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent

Key Trial Info

Start Date :

January 5 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 5 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06112197

Start Date

January 5 2024

End Date

June 5 2025

Last Update

November 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mahmoud Soliman

Sohag, Egypt, 00000

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications | DecenTrialz